Diminished durability of chimeric antigen receptor T-cell efficacy with severe or prolonged postinfusion cytopenias

Affiliations

• ¹ Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
• ² Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
• ³ Molecular, Cellular, and Integrative Physiology, University of California Los Angeles, Los Angeles, California, USA.
• ⁴ Division of General Internal Medicine and Health Services Research, Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
• ⁵ Division of Hematology and Cellular Therapy, Department of Medicine, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.